AIF1 and Stroke: Remarkably, there was a significant (p < 0.05) reduction in Iba1+ area in iNSC treated animals compared to non-treated animals (6.88% ± 2.91% vs. 18.10% ± 6.17%, respectively) demonstrating that iNSC treatment mitigates microglia activation after stroke at the lesion border (Fig. 6E–H).